Hisaka Works (6247) Q1 2026 earnings summary

Executive summary

• Net sales rose 26.6% year-over-year to ¥9,456 million, driven by strong overseas plant projects and pharmaceutical equipment orders.

• Operating profit grew 34.7% to ¥587 million, despite restructuring expenses and a less favorable sales mix.

• Profit attributable to owners of parent increased 25.8% year-over-year to ¥572 million.

• Orders received rose 1.8% year-over-year to ¥10,328 million, with overseas orders up 16.6%.

Financial highlights

• Ordinary profit increased 10.0% year-over-year to ¥775 million.

• Gross profit reached ¥2,391 million, up from ¥2,134 million in the prior year.

• EPS for the quarter was ¥21.19, up from ¥16.14 a year earlier.

• Order backlog rose 8.1% to ¥28,207 million compared to the same quarter last year.

• Comprehensive income totaled ¥1,018 million, up from ¥947 million year-over-year.

Outlook and guidance

• Full-year net sales forecasted at ¥44,000 million, up 14.7% year-over-year.

• Operating profit projected at ¥3,000 million, a 2.4% increase from the previous year.

• Profit attributable to owners of parent expected to decrease 28.9% to ¥2,690 million.

• No changes to previously announced earnings or dividend forecasts.